p = 0.05)
Indications and Limitations of Use Victoza (liraglutide) injection 1.2 mg or 1.8 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes and to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes and established cardiovascular disease
Furthermore, Lachnospiraceae, Lactonifactor , Alistipes and Subdoligranulum were more abundant in HT patients with normal thyroid function while Phascolarctobacterium was more abundant in patients with hypothyroidism
Results vary based on starting weight, adherence to treatment, diet quality, exercise habits, and individual factors
Personalized Plan: Based on your consultation, we'll create a personalized treatment plan tailored to your needs
No mantemos produtos prontos